Copyright
©The Author(s) 2017.
World J Hepatol. Jul 18, 2017; 9(20): 884-895
Published online Jul 18, 2017. doi: 10.4254/wjh.v9.i20.884
Published online Jul 18, 2017. doi: 10.4254/wjh.v9.i20.884
Variable | Patient survival | Graft survival | ||||
HR | 95%CI | P value | HR | 95%CI | P value | |
Univariate analysis | ||||||
Age | 0.796 | 0.973-1.021 | 0.997 | 0.992 | 0.969-1.016 | 0.515 |
Early graft dysfunction | 2.143 | 0.919-4.998 | 0.078 | 1.788 | 0.776-4.123 | 0.173 |
DM | 2.242 | 0.961-5.228 | 0.062 | 2.004 | 0.869-4.618 | 0.103 |
Renal impairment | 4.385 | 2.133-9.017 | < 0.001 | 3.494 | 1.759-6.941 | < 0.001 |
CCI continuous | 3.344 | 1.949-5.738 | < 0.001 | 2.755 | 1.638-4.633 | < 0.001 |
CCI dichotomous | 3.56 | 1.691-7.493 | 0.001 | 2.751 | 1.377-5.494 | 0.004 |
Pre-LRT mechanical ventilation | 3.044 | 1.461-6.342 | 0.003 | 2.456 | 1.210-4.983 | 0.013 |
Pre-LRT vasopressor support | 4.714 | 2.239-9.928 | < 0.001 | 3.618 | 1.758-7.443 | < 0.001 |
Pre-LRT renal replacement therapy | 4.233 | 2.029-8.829 | < 0.001 | 3.271 | 1.630-6.562 | 0.001 |
Transplant from ICU | 2.744 | 1.318-5.712 | 0.007 | 2.101 | 1.049-4.206 | 0.036 |
MELD score ≥ 18 | 4.714 | 2.239-9.928 | 0.009 | 3.105 | 1.399-6.890 | 0.005 |
Encephalopathy at LRT | 2.593 | 1.213-5.544 | 0.014 | 2.28 | 1.121-4.639 | 0.023 |
Hb, g/dL | 0.791 | 0.629-0.994 | 0.044 | 0.792 | 0.636-0.985 | 0.037 |
ABO mismatch | 2.37 | 1.015-5.532 | 0.046 | 2.338 | 1.053-5.190 | 0.037 |
Cold ischemia time (h) | 1.113 | 0.987-1.255 | 0.082 | 1.081 | 0.962-1.216 | 0.191 |
DRI | 0.68 | 0.236-1.963 | 0.476 | 0.693 | 0.250-1.918 | 0.476 |
DRI > 1.8 | 1.736 | 0.772-3.902 | 0.180 | 1.67 | 0.747-3.737 | 0.212 |
Multivariate analysis | ||||||
Renal impairment | 3.215 | 1.147-12.603 | 0.005 | 2.543 | 1.160-5.573 | 0.020 |
CCI Continuous | 2.823 | 1.563-5.101 | 0.001 | 2.350 | 1.331-4.148 | 0.003 |
CCI Dichotomous | 2.87 | 1.306-6.307 | 0.009 | 2.223 | 1.067-4.633 | 0.033 |
Pre-LRT mechanical ventilation | 2.52 | 1.126-5.637 | 0.024 | 2.099 | 0.968-4.552 | 0.060 |
Pre-LRT vasopressor support | 4.004 | 1.554-10.314 | 0.004 | 3.023 | 1.216-7.514 | 0.017 |
Pre-LRT renal replacement therapy | 2.691 | 1.261-5.740 | 0.01 | 2.441 | 1.107-5.383 | 0.027 |
Transplant from ICU | 1.859 | 0.794-4.354 | 0.153 | 1.437 | 0.640-3.230 | 0.380 |
MELD score ≥ 18 | 2.506 | 1.044-6.018 | 0.04 | 2.512 | 1.098-5.743 | 0.029 |
Encephalopathy at LRT | 1.922 | 0.856-4.315 | 0.113 | 1.626 | 0.752-3.515 | 0.217 |
Hb, g/dL at LRT | 0.883 | 0.694-1.125 | 0.314 | 0.883 | 0.698-1.116 | 0.297 |
ABO mismatch | 1.795 | 0.739-4363 | 0.197 | 1.827 | 0.791-4.220 | 0.158 |
- Citation: Al-Freah MAB, Moran C, Foxton MR, Agarwal K, Wendon JA, Heaton ND, Heneghan MA. Impact of comorbidity on waiting list and post-transplant outcomes in patients undergoing liver retransplantation. World J Hepatol 2017; 9(20): 884-895
- URL: https://www.wjgnet.com/1948-5182/full/v9/i20/884.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i20.884